Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Quantitative uptake studies of /sup 131/I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro

Journal Article · · Antimicrob. Agents Chemother.; (United States)
DOI:https://doi.org/10.1128/AAC.25.4.476· OSTI ID:6662888

We have synthesized a /sup 131/I-radiolabeled antiviral compound (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVdU) and shown that this agent was selectively trapped within rabbit kidney cells, infected in vitro by thymidine kinase-positive (TK+) herpes simplex virus (HSV). The uptake of /sup 131/I-labeled IVdU was specific, as it was not concentrated within either HSV (TK-) or mock-infected cells. In certain conditions, over 40% of the radiolabel was selectively trapped within HSV (TK+)-infected cells. This was a 20- to 30-fold increase over the uptake of /sup 131/I-labeled IVdU by HSV (TK-) or mock-infected cells. The uptake of /sup 131/I-labeled IVdU varied directly with (i) the dose of the virus used to infect the rabbit kidney cells; (ii) the concentration of radiolabeled IVdU added to the system; and (iii) the time of exposure of IVdU to infected cells. The ability of this agent to be trapped within HSV (TK+)-infected cells merits further evaluation in animal models as it has potential as a noninvasive, herpes-specific diagnostic test, in particular for HSV encephalitis.

Research Organization:
Faculty of Medicine, University of Alberta, Edmonton, Canada
OSTI ID:
6662888
Journal Information:
Antimicrob. Agents Chemother.; (United States), Journal Name: Antimicrob. Agents Chemother.; (United States) Vol. 25:4; ISSN AMACC
Country of Publication:
United States
Language:
English